Bora Biologics Welcomes Dr. Roger Lias to its Executive Team

“Customers need more than manufacturing capacity. They need a partner who understands their program, communicates openly, and anticipates what comes next. I look forward to working with the Bora Biologics team to help customers build practical manufacturing pathways from development through commercial supply.” – Roger Lias, PhD
Bora Biologics is pleased to welcome Dr. Roger Lias to its executive team. Dr. Lias will lead the company’s global commercial activities, helping customers connect their development and manufacturing needs with Bora Biologics’ mammalian and microbial capabilities.
Dr. Lias brings extensive executive leadership and commercial experience across the global biologics CDMO industry. His background includes commercial roles at Celltech/Lonza and Diosynth, founding management roles at KBI Biopharma, Cytovance Biologics, and Eden Biodesign, and CEO positions at Avid Bioservices and Stelis Biopharma.
More recently, he has supported CDMOs through start-up, growth, and turnaround initiatives and was part of the team involved in the sale of Vibalogics to Recipharm. His experience spans North America, Europe, and Asia-Pacific.
At Bora Biologics, Dr. Lias will work with customers ranging from emerging biotechnology companies to multinational biopharma organizations. His focus will be on understanding each program’s requirements and aligning the right technical expertise, manufacturing capabilities, and commercial approach to support its next milestone.
Bora Biologics supports the development and manufacturing of antibodies and other recombinant proteins derived from mammalian and microbial expression systems. With facilities in Zhubei, Taiwan; Rockville, Maryland; and San Diego, California, our services span cell line development, process development, technology transfer, and GMP manufacturing for clinical and commercial supply.
Dr. Lias’ appointment reinforces Bora Biologics’ commitment to helping customers reduce execution risk, strengthen manufacturing readiness, and move forward with confidence.